1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Mumps Immunisation: new trials by email Literature Review of Mumps Immunisation trials Research Report on Mumps Immunisation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants Pneumococcal Conjugate Vaccine formulation 1, Pneumococcal Conjugate Vaccine formulation 2, Pneumococcal Conjugate Vaccine formulation 3 - Pneumococcal Immunisation, Diphtheria Immunisation | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 852 | 2020-05-22 | 2025-09-08 |
13-valent pneumococcal vaccine (1) · CRM197 (non-toxic variant of diphtheria toxin) (1) · Chickenpox Vaccine (1) · Engerix-B (1) · Hepatitis B Vaccines (1) · Herpes Zoster Vaccine (1) · Measles-Mumps-Rubella Vaccine (1) · RotaTeq (1) · Rotavirus Vaccines (1) · Tetanus Toxoid (1) · pentacel (1)
Sanofi Pasteur, a Sanofi Company (1)
Canada (1) · Honduras (1) · Puerto Rico (1) · United States (1)